Director, New Product Planning, Partnerships EUR / INT (Remote)

If you are a Jazz employee please apply via the Internal Career site

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

Brief Description:

This position resides in New Product Planning-Partnerships, reporting directly to the Head of New Product Planning-Partnerships, and will partner directly with Corporate Development, Search & Evaluation, and NPP colleagues to identify and assess the EUR/INT commercial potential and strategic fit of target assets, as well as partner with EUR/INT and Global leadership on portfolio and market access strategy. This individual will work through each step of the deal process, from initiation to signing, and ensure that strategic and critical success factors for EUR/INT commercialization have been identified. This person must collect and synthesize multiple layers of evidence and insight from a range of sources and across multiple European and international geographies to assess the potential value of a compound or technology. Jazz is committed to long-term growth associated with mergers, acquisitions and partnerships, deal flow and potential to complete transactions is high. Accordingly, for the
position requires a self-motivated, strategically agile and unquestioned collaborator to join the New Product Planning-Partnerships team.

Essential Functions

• Lead commercial assessments (e.g., epidemiology, product positioning and adoption, competitive landscape, pricing and market access) for a wide range of therapeutic areas across 7 key EUR/INT markets (UK, DE, FR, SP, IT, JP and partnered markets), for the purpose of partnerships, licenses and acquisitions


• Partner closely and collaboratively with many functions, such as US/EU Commercial, Search and Evaluation, R&D, Regulatory, and Corporate Development for deal assessments and diligence


• Gather input for all EUR/INT and global deals (neuroscience and oncology) across key EUR/INT stakeholders in marketing, medical, pricing/access, regulatory, and regional general management roles to inform commercial business case


• Gain internal stakeholder alignment and input on deals through regular (monthly or more frequently as needed) updates to a subset of the EUR/INT Leadership team


• Develop detailed annual revenue forecasts extending over a 15-20 year period, and presentations to communicate key inputs, assumptions and scenarios-


• Evaluate commercial synergies and strategic fit with the EUR/INT portfolio, including sales force and SG&A requirements


• Develop executive-level presentations and recommendations to senior management for required commercial investment, including marketing, sales and managed markets


Required Knowledge, Skills, and Abilities

Experiences required for success:

• Superb analytic skills, especially those related to forecasting/modeling


• Track record assessing the clinical and commercial value of an asset in Europe and/or Japan utilizing KOL and internal clinical opinion, published scientific literature, primary market research, syndicated reports and various audits


• Proven track record interfacing and influencing senior leaders and cross-functional collaboration


Following experiences considered a significant plus:

• Experience leading a commercialization planning effort for a near term development or in-line product


• Experience interfacing with key customers including doctors, payers and patients


• Experience with external business development initiatives


• Experience in commercial functions supporting European markets or Japan, such as commercial development, portfolio strategy, pricing/market access or marketing


• Deal transaction familiarity


Required/Preferred Education and Licenses

• 7+ years in management consulting or industry, or combination of relevant experience


• Bachelors in life science and MBA strongly preferred


• Advanced science degree highly valued


Jazz Pharmaceuticals is an Equal Opportunity Employer.
,

Brief Description:

This position resides in New Product Planning-Partnerships, reporting directly to the Head of New Product Planning-Partnerships, and will partner directly with Corporate Development, Search & Evaluation, and NPP colleagues to identify and assess the EUR/INT commercial potential and strategic fit of target assets, as well as partner with EUR/INT and Global leadership on portfolio and market access strategy. This individual will work through each step of the deal process, from initiation to signing, and ensure that strategic and critical success factors for EUR/INT commercialization have been identified. This person must collect and synthesize multiple layers of evidence and insight from a range of sources and across multiple European and international geographies to assess the potential value of a compound or technology. Jazz is committed to long-term growth associated with mergers, acquisitions and partnerships, deal flow and potential to complete transactions is high. Accordingly, for the
position requires a self-motivated, strategically agile and unquestioned collaborator to join the New Product Planning-Partnerships team.

Essential Functions

• Lead commercial assessments (e.g., epidemiology, product positioning and adoption, competitive landscape, pricing and market access) for a wide range of therapeutic areas across 7 key EUR/INT markets (UK, DE, FR, SP, IT, JP and partnered markets), for the purpose of partnerships, licenses and acquisitions


• Partner closely and collaboratively with many functions, such as US/EU Commercial, Search and Evaluation, R&D, Regulatory, and Corporate Development for deal assessments and diligence


• Gather input for all EUR/INT and global deals (neuroscience and oncology) across key EUR/INT stakeholders in marketing, medical, pricing/access, regulatory, and regional general management roles to inform commercial business case


• Gain internal stakeholder alignment and input on deals through regular (monthly or more frequently as needed) updates to a subset of the EUR/INT Leadership team


• Develop detailed annual revenue forecasts extending over a 15-20 year period, and presentations to communicate key inputs, assumptions and scenarios-


• Evaluate commercial synergies and strategic fit with the EUR/INT portfolio, including sales force and SG&A requirements


• Develop executive-level presentations and recommendations to senior management for required commercial investment, including marketing, sales and managed markets


Required Knowledge, Skills, and Abilities

Experiences required for success:

• Superb analytic skills, especially those related to forecasting/modeling


• Track record assessing the clinical and commercial value of an asset in Europe and/or Japan utilizing KOL and internal clinical opinion, published scientific literature, primary market research, syndicated reports and various audits


• Proven track record interfacing and influencing senior leaders and cross-functional collaboration


Following experiences considered a significant plus:

• Experience leading a commercialization planning effort for a near term development or in-line product


• Experience interfacing with key customers including doctors, payers and patients


• Experience with external business development initiatives


• Experience in commercial functions supporting European markets or Japan, such as commercial development, portfolio strategy, pricing/market access or marketing


• Deal transaction familiarity


Required/Preferred Education and Licenses

• 7+ years in management consulting or industry, or combination of relevant experience


• Bachelors in life science and MBA strongly preferred


• Advanced science degree highly valued


Jazz Pharmaceuticals is an Equal Opportunity Employer.

position requires a self-motivated, strategically agile and unquestioned collaborator to join the New Product Planning-Partnerships team.,
• Superb analytic skills, especially those related to forecasting/modeling


• Track record assessing the clinical and commercial value of an asset in Europe and/or Japan utilizing KOL and internal clinical opinion, published scientific literature, primary market research, syndicated reports and various audits


• Proven track record interfacing and influencing senior leaders and cross-functional collaboration


Following experiences considered a significant plus:

• Experience leading a commercialization planning effort for a near term development or in-line product


• Experience interfacing with key customers including doctors, payers and patients


• Experience with external business development initiatives


• Experience in commercial functions supporting European markets or Japan, such as commercial development, portfolio strategy, pricing/market access or marketing


• Deal transaction familiarity


Required/Preferred Education and Licenses

• 7+ years in management consulting or industry, or combination of relevant experience


• Bachelors in life science and MBA strongly preferred


• Advanced science degree highly valued
  
  Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.